Smith-Magenis Syndrome insomnia
Neurology · 2021–2021
1decision
1medicine
1carried consumer input
0individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| melatonin Treatment of insomnia in children aged 2-18 years with Smith-Magenis Syndrome (SMS) where sleep hygiene measures have been insufficient. | Nov 2021 | Recommended | input received Community Controlled Health Organisation |
Who spoke
Community Controlled Health Organisation
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 1 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.